--- title: "Cross-border Expansion and Restructuring: A Cross-section of Global Markets in Late 2026" type: "News" locale: "en" url: "https://longbridge.com/en/news/296906465.md" description: "Against the backdrop of shifting macroeconomic conditions in 2026, companies across sectors are deploying divergent strategies, from accelerating cross-border M&A to initiating deep structural overhauls." datetime: "2026-08-25T11:33:25.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296906465.md) - [en](https://longbridge.com/en/news/296906465.md) - [zh-HK](https://longbridge.com/zh-HK/news/296906465.md) generator: "portal-rs" --- # Cross-border Expansion and Restructuring: A Cross-section of Global Markets in Late 2026 As the third quarter of 2026 progresses, cross-sector movements across global markets have sent their strongest signal yet that corporate strategies are bifurcating sharply against the backdrop of lingering macroeconomic uncertainty. The central tension lies in how different segments of the economy are redefining growth versus survival. Multinational players with robust balance sheets are accelerating cross-border acquisitions in emerging markets, while those facing structural headwinds are retreating into deep defensive restructuring. This divergence underscores that downside risks in late 2026 are increasingly concentrated among peripheral players unable to pivot their asset structures in time. In the realms of critical materials and financial infrastructure, international expansion is moving at a breakneck pace. Sociedad Química y Minera de Chile (SQM.US) reported robust second-quarter revenue of **USD 2.47 billion**, buoyed by a lithium division that saw revenues multiply against the previous year. Projecting global lithium demand to exceed **2.1 million** metric tons in 2026, the company is advancing its Mt Holland expansion. A similar cross-border ambition is playing out in Central Asia, where Kazakhstan-based fintech giant Kaspi.kz (KSPI.US) matched its aggressive **USD 2.3 billion** second-quarter revenue with a strategic entry into Turkey via the acquisition of Rabobank, sending its stock to new highs for the year. The push beyond domestic borders is also visible in digital asset infrastructure. Following regulatory green lights in June 2026, Bakkt (BKKT.US) is pressing ahead with its expansion into India, attempting to capture a rapidly maturing Asian crypto market. Meanwhile, established leaders are utilizing targeted M&A to shore up their global moats. MedTech heavyweight Medtronic (MDT.US) posted **USD 9.8 billion** in fiscal Q4 2026 revenue while swallowing up niche players like Scientia Vascular. In the enterprise software space, Zeta Global (ZETA.US) inked a mid-2026 strategic partnership with Palantir to solidify its AI-driven marketing cloud infrastructure. Yet, the enthusiasm of the tech and materials sectors obscures the painful retooling happening elsewhere. Consumer retail and legacy communications are currently defined by capital defense. Casual footwear maker Crocs (CROX.US) managed **USD 1.18 billion** in second-quarter revenue but has been forced to make aggressive decisions to rein in inventory bloat at its HeyDude brand. The situation is markedly more distressed for EchoStar (ECHO.US), which saw its subsidiary Hughes file for Chapter 11 bankruptcy protection in August 2026 as it attempts to restructure roughly **USD 1.5 billion** in debt. Clinical-stage biotechs are similarly battening down the hatches. Vor Biopharma (VOR.US) updated investors in its second-quarter earnings that careful cash management of its nearly **USD 500 million** reserve should extend its runway into early 2029, as it awaits late-stage trial data. Onconova Therapeutics (ONC.US) continues to navigate difficult clinical development waters, recently posting quarterly losses that missed consensus estimates as it pushes forward with its oncology pipeline. Reflecting the broader market's attempt to digest these disparate realities, the Simplify Volatility Premium ETF (SVIX.US) has maintained steady performance, capitalizing on a persistently subdued VIX index hovering around the **14-15** range. Looking ahead, the resilience of these cross-border expansions will be tested meeting-by-meeting as central banks map out the trajectory for the remainder of the year. For now, those that have pre-emptively repaired their balance sheets appear best positioned to weather whatever spillovers come next. *This article does not constitute investment advice.* ### Related Stocks - [VOR.US](https://longbridge.com/en/quote/VOR.US.md) - [CROX.US](https://longbridge.com/en/quote/CROX.US.md) - [ONC.US](https://longbridge.com/en/quote/ONC.US.md) - [ECHO.US](https://longbridge.com/en/quote/ECHO.US.md) - [MDT.US](https://longbridge.com/en/quote/MDT.US.md) - [KSPI.US](https://longbridge.com/en/quote/KSPI.US.md) - [SQM.US](https://longbridge.com/en/quote/SQM.US.md) - [ZETA.US](https://longbridge.com/en/quote/ZETA.US.md) - [BKKT.US](https://longbridge.com/en/quote/BKKT.US.md) ## Related News & Research - [Medtronic Analysts Raise Their Forecasts After Upbeat Q1 Earnings](https://longbridge.com/en/news/297780375.md) - [Medtronic’s Stars Are Aligning for a Price Recovery](https://longbridge.com/en/news/297677128.md) - [SQM Earnings Call: Record Lithium Volumes, Big Plans](https://longbridge.com/en/news/297411349.md) - [Top AI Healthcare Stocks For September 2026](https://longbridge.com/en/news/297811375.md) - [Sociedad Quimica y Minera S.A. Declares Special Dividend of $1.44 (NYSE:SQM)](https://longbridge.com/en/news/297359387.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**